Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers (Q40265834)

19 September 2017

Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers (English)

1 reference

19 September 2017

Andrew K Sewell

8

0 references

David A Price

object named as

David A Price

6

0 references

Thomas J Scriba

2

object named as

Thomas J Scriba

1 reference

19 September 2017

5

Emma Gostick

1 reference

19 September 2017

Linda Wooldridge

1

1 reference

19 September 2017

Anita Milicic

3

1 reference

19 September 2017

Bruno Laugel

4

1 reference

19 September 2017

Rodney E Phillips

7

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

European Journal of Immunology

19 September 2017

1 reference

19 September 2017

36

1 reference

19 September 2017

7

1 reference

19 September 2017

1847-1855

1 reference

Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.

19 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

High avidity antigen-specific CTL identified by CD8-independent tetramer staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

Characterizing the Impact of CD8 Antibodies on Class I MHC Multimer Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

Monomeric class I molecules mediate TCR/CD3 epsilon/CD8 interaction on the surface of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

The specificity of TCR/pMHC interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Generation and use of alternative multimers of peptide/MHC complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Tracking T cells with tetramers: new tales from new tools

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Functions of tetramer-stained HIV-specific CD4(+) and CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Human CD8 co–receptor is strictly involved in MHC–peptide tetramer–TCR binding and T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Role of CD4 and CD8 in T cell activation and differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Cell-cell adhesion mediated by CD8 and MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635886

7 January 2021

Identifiers

DOI

10.1002/EJI.200635886

1 reference

19 September 2017

1 reference